The Vaccine and Gene Therapy Institute at Oregon Health & Science University has assembled a multidisciplinary team of scientists to respond to serious viral disease threats, including AIDS, chronic viral infection-associated diseases, newly emerging viral diseases and infectious diseases of the elderly. Our programs are intended to span the continuum between basic and clinical science, in which discoveries are rapidly advanced from the level of molecular and cellular biology through animal models and ultimately into clinical testing. Learn more
VGTI Seminar Series and Virology Journal Club is now streamed online. Please reach out to Chad (email@example.com) if you would like a link to the live stream.
Cell Rep. October 25th, 2022
BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age.
Stem Cell Reports. October 18th, 2022
Maternal Western-style diet remodels the transcriptional landscape of fetal hematopoietic stem and progenitor cells in rhesus macaques.
Curr Opin Virol. October 12th, 2022
MicroRNA-mediated control of Epstein-Barr virus infection and potential diagnostic and therapeutic implications
Cell Rep. October 5th, 2022
BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age
Psychosom Med. October 1st, 2022
Individual differences in CD4/CD8 T-cell ratio trajectories and associated risk profiles modeled from acute HIV infection